- Report
- July 2023
- 46 Pages
Japan
From €319EUR$350USD£271GBP
- Report
- July 2023
- 45 Pages
Germany
From €319EUR$350USD£271GBP
- Report
- July 2023
- 45 Pages
United States
From €319EUR$350USD£271GBP
- Report
- July 2023
- 47 Pages
Russia
From €319EUR$350USD£271GBP
- Report
- July 2023
- 47 Pages
China
From €319EUR$350USD£271GBP
- Report
- July 2023
- 44 Pages
North America
From €319EUR$350USD£271GBP
- Report
- July 2023
- 41 Pages
Indonesia
From €319EUR$350USD£271GBP
- Report
- July 2023
- 45 Pages
Australia
From €319EUR$350USD£271GBP
- Report
- July 2023
- 47 Pages
Netherlands
From €319EUR$350USD£271GBP
- Report
- July 2023
- 44 Pages
South Africa
From €319EUR$350USD£271GBP
- Report
- July 2023
- 41 Pages
Global
From €319EUR$350USD£271GBP
- Report
- July 2023
- 45 Pages
Asia Pacific
From €319EUR$350USD£271GBP
- Report
- March 2024
- 97 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP

Branded generics are generic drugs that are marketed under a brand name. They are typically manufactured by a generic drug company, but are sold under a brand name owned by a pharmaceutical company. Branded generics are typically sold at a higher price than generic drugs, but are still much cheaper than the original brand-name drug. They are often used to increase the market share of a generic drug company, as well as to increase the visibility of a generic drug in the marketplace.
Branded generics are becoming increasingly popular in the pharmaceutical industry, as they offer a cost-effective alternative to brand-name drugs. They are also used to increase the market share of generic drug companies, as well as to increase the visibility of generic drugs in the marketplace.
Some companies in the branded generics market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less Read more